RecruitingPhase IEN original

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study is to find out whether the combination of epcoritamab and ibrutinib is a safe treatment approach that causes few or mild side effects in people with relapsed/refractory primary central nervous system lymphoma (PCNSL) or secondary central nervous system lymphoma (SCNSL).

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek co najmniej 18 lat
  • Potwierdzony chłoniak typu DLBCL (poprzez biopsję lub pobranie płynu)
  • Stan ogólny organizmu pozwalający na aktywność codzienną (ECOG 0-2)
  • Wystarczająca funkcja szpiku kostnego i narządów wewnętrznych
  • Liczba płytek krwi powyżej 75 miliardów na litr
  • Hemoglobina powyżej 8 g/dL
  • Prawidłowa funkcja wątroby i nerek
  • Kobiety w wieku rozrodczym muszą stosować antykoncepcję przez czas leczenia i 30 dni po

✗ Disqualifies

  • Chłoniak po raz pierwszy zdiagnozowany (nowy)
  • Chłoniak poza ośrodkowym układem nerwowym

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 14, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (8)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, United States

Memorial Sloan Kettering Commack (Limited Protocol Activities)

Commack, United States

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Harrison, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Uniondale, United States

University of Utah (Data Collection Only)

Salt Lake City, United States

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.